We are live on ! Find out more
Prudential Financial

Prudential Financial Portfolio holdings

AUM $81.2B
1-Year Est. Return 27.81%
This Fund
S&P 500
This Quarter Est. Return
+12.73%
1 Year Est. Return
+27.81%
3 Year Est. Return
+94.87%
5 Year Est. Return
+128.33%
10 Year Est. Return
+450.33%
AUM
$66.2B
AUM Growth
+$2.36B
Cap. Flow
-$4.34B
Cap. Flow %
-6.56%
Top 10 Hldgs %
26.27%
Holding
2,763
New
170
Increased
1,022
Reduced
1,381
Closed
119

Sector Composition

Rank Sector Weight
1 Technology 23.67%
2 Financials 10.79%
3 Healthcare 10.73%
4 Consumer Discretionary 9.54%
5 Industrials 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PL icon
2601
Planet Labs
PL
$7.3B
$26.5K ﹤0.01%
10,715
NGM
2602
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$25.6K ﹤0.01%
+29,785
New +$26.2K
CTMX icon
2603
CytomX Therapeutics
CTMX
$705M
$25.3K ﹤0.01%
16,300
CHPT icon
2604
ChargePoint
CHPT
$133M
$25K ﹤0.01%
+534
New +$29.9K
INUV icon
2605
Inuvo
INUV
$16M
$24.1K ﹤0.01%
+5,660
New +$14.8K
SCYX icon
2606
SCYNEXIS
SCYX
$37M
$23.6K ﹤0.01%
1,325
RNAC icon
2607
Cartesian Therapeutics
RNAC
$232M
$23.4K ﹤0.01%
1,130
BNGO icon
2608
Bionano Genomics
BNGO
$12.7M
$23.2K ﹤0.01%
+205
New +$21.4K
SHCR
2609
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$22K ﹤0.01%
20,395
+1,730
+9% +$1.77K
FSR
2610
DELISTED
Fisker Inc.
FSR
$21.9K ﹤0.01%
12,517
KPTI icon
2611
Karyopharm Therapeutics
KPTI
$168M
$21.5K ﹤0.01%
1,654
+360
+28% +$4.85K
ATYR
2612
aTyr Pharma
ATYR
$46.4M
$21.4K ﹤0.01%
+15,200
New +$19.5K
KYNB
2613
Kyntra Bio
KYNB
$28.5M
$21.1K ﹤0.01%
952
XGN icon
2614
Exagen
XGN
$113M
$21.1K ﹤0.01%
10,600
AGEN
2615
Agenus
AGEN
$249M
$20.2K ﹤0.01%
1,222
+125
+11% +$2.07K
PVLA
2616
Palvella Therapeutics
PVLA
$1.98B
$20.1K ﹤0.01%
1,378
GEVO icon
2617
Gevo
GEVO
$397M
$19.8K ﹤0.01%
17,090
-322,630
-95% -$368K
MVST icon
2618
Microvast
MVST
$267M
$19.2K ﹤0.01%
+13,715
New +$18.4K
IAUX
2619
i-80 Gold Corp
IAUX
$1.17B
$18.5K ﹤0.01%
+10,520
New +$16.2K
KZR
2620
DELISTED
Kezar Life Sciences
KZR
$17.8K ﹤0.01%
1,898
-1,755
-48% -$15.4K
ME
2621
DELISTED
23andMe Holding Co
ME
$16.7K ﹤0.01%
915
+173
+23% +$2.99K
LVO icon
2622
LiveOne
LVO
$66M
$16.7K ﹤0.01%
1,200
-2,720
-69% -$28.8K
NKTR icon
2623
Nektar Therapeutics
NKTR
$2.39B
$15.9K ﹤0.01%
1,880
+507
+37% +$3.84K
BLUE
2624
DELISTED
bluebird bio
BLUE
$15.9K ﹤0.01%
+575
New +$35.1K
VRM icon
2625
Vroom Inc
VRM
$36.9M
$15.8K ﹤0.01%
327

Similar funds

Prudential Financial's Q4 2023 Portfolio in Review

As of Q4 2023, Prudential Financial held 2,763 positions worth $66.2B, up 3.7% from $63.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Prudential Financial withdrew a net $4.34B in Q4 2023, closing 119 positions and reducing 1,381 holdings. Its most notable exit was Activision Blizzard, an estimated $60.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Prudential Financial opened a new position in Tricon Residential Inc. worth $48.4M.

  • Prudential Financial's largest Q4 2023 buy was Tricon Residential Inc.: 5,310,217 shares worth $48.4M.
  • Prudential Financial added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $1.17B increase.
  • Prudential Financial's biggest Q4 2023 reduction was Microsoft, cutting an estimated $417M.
  • Prudential Financial fully exited Activision Blizzard in Q4 2023, selling an estimated $60.3M.
  • Prudential Financial's ten largest holdings make up 26% of its $66.2B portfolio in Q4 2023.
  • Prudential Financial opened 170 new positions and closed 119 in Q4 2023.
  • Prudential Financial's portfolio value rose 3.7% quarter-over-quarter to $66.2B.

Based on Prudential Financial's 13F filing for Q4 2023, filed 13 Feb 2024.